This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IMRIS Launches World's First MR-safe And CT-compatible Neurosurgical Horseshoe Headrest

Provides non-rigid head positioning for pediatric and adult patients during brain surgery and intraoperative imaging in the VISIUS Surgical Theatre

MINNEAPOLIS, Feb. 19, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the initial launch of the world's first MR-safe and CT-compatible horseshoe headrest on the market for the positioning of patients ranging from neonatal to adult during neurosurgical procedures requiring intraoperative imaging in the VISIUS ® Surgical Theatre.

The horseshoe headrest provides non-pinned head support in prone, lateral, and supine positions during head, neck and cervical spine surgeries where use of a head fixation device (HFD) - a clamp-like device - is not desirable because the skull is too fragile for pinning. These patients may be babies whose skulls are still soft or older patients with weakened skull bones.

"The IMRIS horseshoe headrest expands the use of intraoperative imaging to patients who cannot be positioned for surgery with a head fixation device, such as neonatal and young pediatric patients. This headrest may also be useful for other applications not requiring rigid fixation, such as those that access the skull through the nose," said Dr. James Baumgartner, Surgical Director of the Comprehensive Pediatric Epilepsy Center at Florida Hospital. "This will enhance an already sophisticated technology platform that includes intraoperative MR and the comprehensive team approach we have for pediatric tumor and epilepsy care."

IMRIS President and CEO Jay D. Miller said surgeons at hospitals with VISIUS systems which adopt the headrest will now have an opportunity to benefit both a patient population - including those too small for other positioning devices - and procedures not previously utilized in the surgical theater. "We received tremendous feedback and enthusiasm from pediatric neurosurgeons during development of this product," he said. "This headrest will allow surgeons to use iMR on more patients who we expect will benefit from the same outcomes, including reduced re-operation rates, which we have recently reported from hospitals.

"In addition, the headrest which is designed for patient comfort and smooth staff workflow includes disposable elements," Miller said. "This first release in our disposable product portfolio establishes the company's capabilities to develop tools that speed case-to-case transition and optimize patient handling."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs